These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9116302)

  • 21. Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients.
    Pallis FR; Conran N; Fertrin KY; Olalla Saad ST; Costa FF; Franco-Penteado CF
    Br J Haematol; 2014 Jan; 164(2):286-95. PubMed ID: 24383847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of hydroxyurea on blood rheology in sickle cell anemia: A two-years follow-up study.
    Lemonne N; Möckesch B; Charlot K; Garnier Y; Waltz X; Lamarre Y; Antoine-Jonville S; Etienne-Julan M; Hardy-Dessources MD; Romana M; Connes P
    Clin Hemorheol Microcirc; 2017; 67(2):141-148. PubMed ID: 28759962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo pharmaco-proteomic analysis of hydroxyurea induced changes in the sickle red blood cell membrane proteome.
    Ghatpande SS; Choudhary PK; Quinn CT; Goodman SR
    J Proteomics; 2010 Jan; 73(3):619-26. PubMed ID: 19914412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher oxygen saturation with hydroxyurea in paediatric sickle cell disease.
    van Geyzel L; Arigliani M; Inusa B; Singh B; Kozlowska W; Chakravorty S; Bossley CJ; Ruiz G; Rees D; Gupta A
    Arch Dis Child; 2020 Jun; 105(6):575-579. PubMed ID: 31871045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy.
    Saleh AW; Hillen HF; Duits AJ
    Acta Haematol; 1999; 102(1):31-7. PubMed ID: 10473885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intercellular adhesion molecule-4 and CD36 are implicated in the abnormal adhesiveness of sickle cell SAD mouse erythrocytes to endothelium.
    Trinh-Trang-Tan MM; Vilela-Lamego C; Picot J; Wautier MP; Cartron JP
    Haematologica; 2010 May; 95(5):730-7. PubMed ID: 20015873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxyurea and erythropoietin therapy in sickle cell anemia.
    Goldberg MA; Brugnara C; Dover GJ; Schapira L; Lacroix L; Bunn HF
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):74-81. PubMed ID: 1379376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxyurea therapy decreases the in vitro adhesion of sickle erythrocytes to thrombospondin and laminin.
    Hillery CA; Du MC; Wang WC; Scott JP
    Br J Haematol; 2000 May; 109(2):322-7. PubMed ID: 10848818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease.
    el-Hazmi MA; al-Momen A; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F; Warsy AS
    Acta Haematol; 1995; 94(3):128-34. PubMed ID: 7502628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia.
    Koren A; Segal-Kupershmit D; Zalman L; Levin C; Abu Hana M; Palmor H; Luder A; Attias D
    Pediatr Hematol Oncol; 1999; 16(3):221-32. PubMed ID: 10326220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophils remain detrimentally active in hydroxyurea-treated patients with sickle cell disease.
    Barbu EA; Dominical VM; Mendelsohn L; Thein SL
    PLoS One; 2019; 14(12):e0226583. PubMed ID: 31869367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice.
    Almeida CB; Scheiermann C; Jang JE; Prophete C; Costa FF; Conran N; Frenette PS
    Blood; 2012 Oct; 120(14):2879-88. PubMed ID: 22833547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and hematological effects of hydroxyurea therapy in sickle cell patients: a single-center experience in Brazil.
    Silva-Pinto AC; Angulo IL; Brunetta DM; Neves FI; Bassi SC; Santis GC; Covas DT
    Sao Paulo Med J; 2013; 131(4):238-43. PubMed ID: 24141294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia.
    Joneckis CC; Ackley RL; Orringer EP; Wayner EA; Parise LV
    Blood; 1993 Dec; 82(12):3548-55. PubMed ID: 7505118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of sickle cell anemia with hydroxyurea and erythropoietin.
    Goldberg MA; Brugnara C; Dover GJ; Schapira L; Charache S; Bunn HF
    N Engl J Med; 1990 Aug; 323(6):366-72. PubMed ID: 1695325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary benefit of maintaining normal transcranial Doppler velocities when using hydroxyurea for prevention of severe sickle cell anemia.
    Ghafuri DL; Chaturvedi S; Rodeghier M; Stimpson SJ; McClain B; Byrd J; DeBaun MR
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaso-occlusion in sickle cell anemia: role of interactions between blood cells and endothelium.
    Elion JE; Brun M; Odièvre MH; Lapouméroulie CL; Krishnamoorthy R
    Hematol J; 2004; 5 Suppl 3():S195-8. PubMed ID: 15190308
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
    Charache S
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.